ACL narrowed full-year loss (7 Feb 2014, Reuters) on weaker rand & firmer steel price which offset decline in sales.
Diluted headline loss/share (31 Dec 2014) 56c, prev year loss/share 129c.
UBS raised target price to R50 from 46.30, rating neutral.
Company expected improved Q1 performance (on international price pickup & higher sales volume after seasonal slowdown Q4)
Despite all this, I changed this one from my short watch list to short now until at least end Apr. Q1 Earnings release 9 May.
Anybody aware of a reason (except above ones) not to do this?
Input guys?